Nephritic syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Nephritic syndrome}} | {{Nephritic syndrome}} | ||
{{CMG}}; {{AE}} [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]] | |||
The yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies.<ref name="pmid21068142">{{cite journal| author=McGrogan A, Franssen CF, de Vries CS| title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. | journal=Nephrol Dial Transplant | year= 2011 | volume= 26 | issue= 2 | pages= 414-30 | pmid=21068142 | doi=10.1093/ndt/gfq665 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21068142 }} </ref> Additionally, the true incidence is difficult to predict because the disease might present subclinically. | ==Overview== | ||
Approximately 25% of patients with acute glomerulonephritis present with nephritic syndrome.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref> Acute glomerulonephritis accounts for 10-15% of glomerular diseases in the USA.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref> The reported incidence rates of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1.<ref name="pmid21068142">{{cite journal| author=McGrogan A, Franssen CF, de Vries CS| title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. | journal=Nephrol Dial Transplant | year= 2011 | volume= 26 | issue= 2 | pages= 414-30 | pmid=21068142 | doi=10.1093/ndt/gfq665 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21068142 }} </ref> The most common cause of glomerulonephritis worldwide is IgA nephropathy (Berger disease). Approximately 25-30% of patients eventually develop end-stage renal disease (ESRD).<ref name="pmid21068142">{{cite journal| author=McGrogan A, Franssen CF, de Vries CS| title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. | journal=Nephrol Dial Transplant | year= 2011 | volume= 26 | issue= 2 | pages= 414-30 | pmid=21068142 | doi=10.1093/ndt/gfq665 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21068142 }} </ref> The yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies.<ref name="pmid21068142">{{cite journal| author=McGrogan A, Franssen CF, de Vries CS| title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. | journal=Nephrol Dial Transplant | year= 2011 | volume= 26 | issue= 2 | pages= 414-30 | pmid=21068142 | doi=10.1093/ndt/gfq665 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21068142 }} </ref> Additionally, the true incidence is difficult to predict because the disease might present subclinically. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:44, 3 April 2015
|
Nephritic syndrome Microchapters |
|
Treatment |
|---|
|
Case Studies |
|
Nephritic syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Nephritic syndrome epidemiology and demographics |
|
Nephritic syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Nephritic syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian
Overview
Approximately 25% of patients with acute glomerulonephritis present with nephritic syndrome.[1] Acute glomerulonephritis accounts for 10-15% of glomerular diseases in the USA.[2] The reported incidence rates of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1.[3] The most common cause of glomerulonephritis worldwide is IgA nephropathy (Berger disease). Approximately 25-30% of patients eventually develop end-stage renal disease (ESRD).[3] The yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies.[3] Additionally, the true incidence is difficult to predict because the disease might present subclinically.
References
- ↑ Chang, A (2009). Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease. Springer. pp. 711–6. Unknown parameter
|coauthors=ignored (help) - ↑ Chang, A (2009). Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease. Springer. pp. 711–6. Unknown parameter
|coauthors=ignored (help) - ↑ 3.0 3.1 3.2 McGrogan A, Franssen CF, de Vries CS (2011). "The incidence of primary glomerulonephritis worldwide: a systematic review of the literature". Nephrol Dial Transplant. 26 (2): 414–30. doi:10.1093/ndt/gfq665. PMID 21068142.